Belpointe Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Belpointe Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$908K	Buy	27,467 +10,729	+64%	+$454K	0.03%	493
2025 Q4	$775K	Buy	16,738 +3,048	+22%	+$128K	0.03%	526
2025 Q3	$479K	Hold	13,690	–	–	0.02%	641
2025 Q2	$405K	Buy	13,690 +30	+0.2%	+$856	0.02%	654
2025 Q1	$408K	Buy	+13,660	New	+$417K	0.02%	619
2023 Q2	–	Sell	-1,144	Closed	-$27.4K	–	1111
2023 Q1	$27.4K	Buy	1,144 +228	+25%	+$6.05K	﹤0.01%	2115
2022 Q4	$21.3K	Buy	+916	New	+$18.5K	﹤0.01%	2140

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Belpointe Asset Management's COLL Position: Q1 2026 in Review

Belpointe Asset Management increased its Collegium Pharmaceutical (COLL) stake by 64% in Q1 2026, buying an estimated $454K and bringing the position to 27,467 shares worth $908K. The position accounts for 0.03% of the portfolio, ranked #493.

Belpointe Asset Management first reported a position in COLL in Q4 2022 and has held it in 7 quarters since. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

Belpointe Asset Management held 27,467 shares of Collegium Pharmaceutical worth $908K as of Q1 2026.
Belpointe Asset Management bought 10,729 Collegium Pharmaceutical shares in Q1 2026, an estimated $454K.
Collegium Pharmaceutical made up 0.03% of Belpointe Asset Management's portfolio in Q1 2026, its #493 holding.
Belpointe Asset Management first reported a position in Collegium Pharmaceutical in Q4 2022 and has held it in 7 quarters since.
266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.